The share capital increase has been duly registered in the
-End-
Contacts
CEO,
ir@bergenbio.com
CFO,
Rune.skeie@bergenbio.com
Forward looking statements
This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
http://publish.ne.cision.com//Release/ViewReleaseHtml/C7E26D5060537EA8E0C856B0705FC7D6
https://mb.cision.com/Main/15728/3455837/1497862.pdf
(c) 2021 Cision. All rights reserved., source